| preventing respiratory virus transmission | |
| potential COVID-19 treatments | |
| adjuvant therapies | |
| face mask | Aiello Lau Balaban Alfelali Suess Uchida Choudhry Jolie Barasheed Wu Deris Sung A EFFACER Canini Emamian Tahir Cowling MacIntyre Gautret Larson Aiello MacIntyre Hashim Cowling Kim Simmerman Zein MacIntyre Lau Al-Jasser Shin |
| antiviral and associated therapy | |
| favipiravir | Zhao |
| 5347 | Mehra, 2020 | 2 | 12 | 4 | excluded | not a RCT | high risk of bias |
| 5521 | Del Amo, 2020 | 2 | 0 | 0 | excluded | risk of bias not avaialble | |
| 7070 | PHE variants (Technical briefing 12 22 may 2021), 2021 | 2 | 20 | 2 | excluded | not a RCT | |
| 7420 | PHE (Stowe), 2021 | 2 | 13 | 3 | excluded | not a RCT | high risk of bias |
| 8149 | PHE Technical briefing 16 (11/18 June 2021), 2021 | 2 | 13 | 3 | excluded | not a RCT | high risk of bias |
| 8275 | Musser, 2021 | 2 | 13 | 0 | excluded | not a RCT | risk of bias not avaialble |
| 8350 | Rosenberg, 2021 | 2 | 13 | 0 | excluded | not a RCT | risk of bias not avaialble |
| 8515 | Scobie, 2021 | 2 | 20 | 0 | excluded | not a RCT | risk of bias not avaialble |
| 9170 | UKHSA report 33 (23 december 2021), 2021 | 2 | 20 | 0 | excluded | not a RCT | risk of bias not avaialble |
| 9176 | UKHSA 31 december 2021, 2021 | 2 | 20 | 0 | excluded | not a RCT | risk of bias not avaialble |
| 9214 | Southern California (Lewnard), 2022 | 2 | 13 | 0 | excluded | not a RCT | risk of bias not avaialble |
| 9294 | UKHSA (report W4- 27 January), 2022 | 2 | 12 | 0 | excluded | not a RCT | risk of bias not avaialble |
-
About us
-
Contact us
-
Method
-
RSS
Made with
in Lyon
-
Credits
-
Privacy policy
-
